Adjuvant chemotherapy in pathological node-negative non-small cell lung cancer

Non–small cell lung cancer (NSCLC) is associated with a poor survival rate, even for patients with early-stage cancer. Identifying patients with pathological N0 NSCLC who may benefit from adjuvant chemotherapy treatment after surgery is essential. We conducted a retrospective cohort study used data...

Descripción completa

Detalles Bibliográficos
Autores principales: Cheng, Ya-Fu, Chen, Yi-Ling, Liu, Chia-Chi, Lin, Ching-Min, Tong, Shao-Syuan, Wang, Bing-Yen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10628181/
https://www.ncbi.nlm.nih.gov/pubmed/37932436
http://dx.doi.org/10.1038/s41598-023-46679-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10628181/
https://www.ncbi.nlm.nih.gov/pubmed/37932436
http://dx.doi.org/10.1038/s41598-023-46679-8

Ejemplares similares